DNA - Ginkgo Bioworks Holdings, Inc.
6.5
-0.340 -5.231%
Share volume: 940,284
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$6.84
-0.34
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-25-2025 | 05-06-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | -203.000 K | -207.000 K | 9.938 M | 8.142 M | |
| Other financing cash flows | -203.000 K | -207.000 K | -24.000 K | -25.000 K | |
| Cash flow | -55.723 M | -250.412 M | -94.484 M | 55.563 M | |
| Net income | -107.534 M | -90.957 M | -80.755 M | -80.751 M | |
| Depreciation | 15.652 M | 15.366 M | 14.168 M | 13.663 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -13.085 M | -198.684 M | -72.816 M | 95.099 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 120.000 K | 249.000 K | -461.000 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 13.653 M | 7.622 M | 0.000 | -569.000 K | |
| Cash Change | -55.796 M | -250.338 M | -94.391 M | 55.411 M |